Managing Type 2 diabetes is a tricky preposition and two of the most common bariatric surgery- Gastric bypass and sleeve gastrectomy have been found to be far more effective in treating the condition in overweight patients. The study was presented at the American College of Cardiology’s 63rd Annual Scientific Session.
The study Code Named STAMPEDE is one of the biggest randomized controlled studies which have been done to compare the effectiveness of the two procedures mentioned above and intensive medicinal therapy in achieving effective glycemic control. Benchmarks for Glycemic control in the study were more aggressive at 6% or lower than those set by American Diabetes Association recommendation of 7 percent.
After a three year follow-up the results were as follows-
5 percent of patients in the medical therapy group met this primary endpoint as compared to 37.5 percent of gastric bypass and 24.5 percent of sleeve gastrectomy patients. The surgical patient group also showed significant improvement in major cardiovascular risk parameters like BMI, Weight Control, HDL and Triglyceride levels.
According to Philip Schauer, M.D., professor of surgery, director of the Bariatric and Metabolic Institute, Cleveland Clinic, and lead investigator of the study, “Both surgical options maintain their supremacy over standard intensive medical therapy at the three-year mark. There is this notion that if we keep adding medications and pushing patients to lose weight on their own, they will eventually achieve the same type of results as those undergoing surgery, but that wasn’t the case here.”
The Surgical Group showed prognosis which were fairly constant. The group receiving Medicines showed dramatic improvement in glysemic control in the first year but were almost back to baseline in three years time. The Blood Glucose levels which was 9.5 at the start of the medicinal therapy, dropped to as low as 7.5 and was back to 8.4 levels in three years. On the other hand the surgical groups were able to maintain a lower glucose level with an average 2.5 percent reduction. The Blood Glucose levels which was 9.3 at the start of the medicinal therapy, was lowered to 6.7 and 7.0 for gastric bypass and sleeve gastrectomy at year three